RareCyte logo


RareCyte is a precision biology solution focused on the multiplexed analysis of cells and tissue with applications in both research and clinical diagnostics.

Seattle, WA

CEO: Joe Victor
Arboretum Lead: Jan Garfinkle

November 16, 2022 in News Page, RareCyte

RareCyte® selected for the Wellcome Leap In Utero program

RareCyte Inc., ("RareCyte" or "The Company") a leading provider of Precision Biology products and services has been selected by Wellcome Leap to participate in the $50M In Utero program to create…
Read More
September 9, 2021 in Home Page, News Page, RareCyte

RareCyte® Secures $24M Financing to Advance the Orion™ Spatial Biology Platform

RareCyte, Inc. (“RareCyte” or “the Company”) a Life Sciences company developing and manufacturing proprietary platforms enabling precision biology solutions, announced today the completion of a $24M financing from new and…
Read More